To evaluate whether oral supplementation with arginine affects the humoral and innate immune response after vaccination against Streptococcus pneumoniae in a group of people aged 60 y and older, free-living in the community.
A randomized controlled trial with one supplemented group and one control group.
Older persons living in the community.
A total of 29 adults aged 60 y and older.
The older people were randomized into two groups, one with arginine supplementation (15 g/day) for 4 weeks after pneumococcal vaccine. The control group received only the vaccine. Anthropometric measurements and immune system function parameters: neutrophil chemotaxis and phagocytosis, natural killer cell activity, determination of serum pneumococcal polysaccharide antibodies and serum C3 and C4.
Neutrophil phagocytosis and the serum concentration of complement (C3 and C4) did not differ between groups. IgG antibodies against pneumococcal polysaccharide serotypes 1, 5 and 6B increased in both groups. The following parameters increased in the arginine-supplemented group compared to the nonsupplemented group: neutrophil chemotaxis (34 vs 19 units of migration, P=0.002), natural killer cell cytotoxicity (23.3 vs 13.4 10 M/Ul 40%, P=0.011) and IgG against antigen 5 (12.3 vs 6.2 μg/ml, P=0.044).
This study suggests that, after the pneumococcal vaccine, the intake of arginine increased neutrophil chemotaxis, natural killer cytotoxicity and serum concentration of IgG against antigen 5 in older people. These results suggest that arginine supplementation may enhance the immune response elicited by the pneumococcal vaccine in older people.
Supported in part by CAPES and FAEPA.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Immunity & Ageing Open Access 25 January 2018
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Alexander JW (2002): Nutritional pharmacology in surgical patients. Am. J. Surg. 183, 349–352.
Azzara A, Carulli G, Sbrana S, Rizzuti-Gullaci A, Minnucci S, Natale M & Ambrogi F (1995): Effects of lysine–arginine association on immune functions in patients with recurrent infections. Drugs Exp. Clin. Res. 21, 71–78.
Barbul A, Sisto DA, Wasserkrug BA & Efron G (1981): Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 90, 244–250.
Bender BS (2003): Infectious disease risk in the elderly. Immunol. Allergy Clin. North Am. 23, 57–64.
Brandileone MC, de Andrade AL, Di Fabio JL, Guerra ML & Austrian R (2003): Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. J. Infect. Dis. 187, 1206–1212.
Brittenden J, Park KGM, Heys SD, Ross C, Ashby J, Ah-See AK & Eremin O (1994): L-arginine stimulates host defenses in patients with breast cancer. Surgery 115, 205–212.
Bryant J, Day R, Whiteside TL & Herberman RB (1992): Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods 146, 91–103.
Burns EA (2004): Effects of aging on immune function. J. Nutr. Health Aging 8, 9–18.
Corberand J, Ngyen F, Laharrague P, Fontanilles AM, Gleyzes B, Gyrard E & Senegas C (1981): Polymorphonuclear functions and aging in humans. J. Am. Geriatr. Soc. 29, 391–397.
Donadi EA & Falcão RP (1987): Neutrophil chemotaxis in sickle cell anaemia, sickle cell β thalassaemia, and after splenectomy. J. Clin. Pathol. 40, 670–672.
Efron D & Barbul A (2000): Role of arginine in immunonutrition. J. Gastroenterol. 35, 20–23.
Fossel M (2002): Cell senescence in human aging and disease. Ann. NY Acad. Sci. 959, 14–23.
Go ES & Ballas ZK (1996): Anti-pneumococcal antibody in normal subjects: a meta-analysis. J. Allergy Clin. Immunol. 98, 205–215.
Kirk SJ, Hurson M, Regan MC, Holt DR, Wasserkrug HL, Barbul A, Daly JM & Flye MW (1994): Arginine stimulates wound healing and immune function in elderly human-beings. Surgery 114, 155–160.
Koivula I, Stén M, Leinonen M & Makela PH (1997): Clinical efficacy of pneumoccocal vaccine in the elderly: a randomized single-blind population-based trial. Am. J. Med. 103, 281–290.
Jackson LA, Neuzil KM, Yu OC, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK & Thompson WW (2003): Effectiveness of pneumococcal polysaccharide vaccine in older adults. N. Engl. J. Med. 348, 1747–1755.
Lace JK, Tan JS & Watanakunakorn C (1975): An appraisal of the Nitroblue Tetrazolium Reduction Test. Am. J. Med. 58, 685–694.
Lahood N, Emerson S, Kumar P & Sorensen RU (1993): Antibody levels and response to pneumoccocal vaccine in steroid-dependent asthma. Ann. Allergy 70, 289–294.
Lesourd B (2004): Nutrition: a major factor influencing immunity in the elderly. J. Nutr. Health Aging 8, 28–37.
Muhling J, Fuchs M, Fleck C, Sablotzki A, Krull M, Dehne MG, Gonter J, Weiss S & Engel J (2002): Effects of arginine, L-alanyl-L-glutamine or taurine on neutrophil (PMN) free amino acid profiles and immune function in vitro. Amino Acids 22, 39–53.
Nieves Jr C & Langkamp-Henken B (2002): Arginine and immunity: a unique perspective. Biomed. Pharmacother. 56, 471–482.
Provinciali M, Montenovo A, Stefano GD, Colombo M, Daghetta L, Cairati M, Veroni C, Cassino R, Della Torre F & Fabris N (1998): Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Age. 7, 715–722.
Sankilampi U, Honkanen P, Bloigu A & Leinonen M (1996): Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J. Infect. Dis. 173, 387–393.
Schueren MAE, Quak JJ, Flier BME, Kuik DJ, Snow GB, Green CJ & Leevwen PAM (2001): Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am. J. Clin. Nutr. 73, 323–332.
Suchner U, Heyland DK & Peter K (2002): Immune-modulatory actions of arginine in the critically ill. Br. J. Nutr. 87, 121–132.
Urban L, Bessenyei B, Marka M & Semsei I (2002): On the role of aging in the etiology of autoimmunity. Gerontology 48, 179–184.
Vannucchi H & Marchini JS (1996): Avaliação do estado nutricional. Medicina 1, 5–18.
We are grateful to Dr Julio C Voltarelli, Dr Roberto Passetto Falcão and Vera Simonsen D Vieira for providing the Laboratories for the necessary analyses, and to Maria do Rosário del Lama Unamuno for performing all anthropometric evaluations.
Guarantors: JC Moriguti, JS Marchini.
Contributors: JCM carried out this study as part of his PhD project and was responsible for recruitment of patients and for laboratory assays. The work was supervised by JSM and EAD who also analyzed data together with JCM. The paper was drafted by JCM and EF. All authors reviewed and approved the final version.
About this article
Cite this article
Moriguti, J., Ferriolli, E., Donadi, E. et al. Effects of arginine supplementation on the humoral and innate immune response of older people. Eur J Clin Nutr 59, 1362–1366 (2005). https://doi.org/10.1038/sj.ejcn.1602247
This article is cited by
Immunity & Ageing (2018)
Amino Acids (2016)